Tokyo, Dec. 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060206) titled 'Factors Associated with Treatment Decision-Making in Cancer Patients Who Place Priority on Quality of Life: A Scoping Review' on Dec. 25.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Tokyo University of Pharmacy and Life Sciences
Condition:
Condition - patients with unresectable advanced cancer and/or recurrent disease
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To identify factors underlying older cancer patients preference for quality of life over chemotherapy aimed at life prolongation
Basic objectives2 - Others
Eligibility:
Age-lower limit - 65
years-old
Gender - Male and Female
Key inclusion criteria - Population:Patients with cancer
Concept:Factors influencing decision-making that prioritizes quality of life over life-prolonging chemotherapy, including patients' values, symptom burden, family structure, socioeconomic circumstances, and relationships with physicians
Context:Decision-making in cancer treatment settings, regardless of outpatient or inpatient care
Key exclusion criteria - Research using languages other than Japanese or English.
Excluding review articles, commentaries, and conference proceedings.
Recruitment Status:
Recruitment status - Completed
Date of protocol fixation - 2025 Year 11 Month 17 Day
Date of IRB - 2025 Year 11 Month 17 Day
Anticipated trial start date - 2025 Year 11 Month 17 Day
Last follow-up date - 2025 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068861
Disclaimer: Curated by HT Syndication.
